JP2019514343A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019514343A5 JP2019514343A5 JP2018542268A JP2018542268A JP2019514343A5 JP 2019514343 A5 JP2019514343 A5 JP 2019514343A5 JP 2018542268 A JP2018542268 A JP 2018542268A JP 2018542268 A JP2018542268 A JP 2018542268A JP 2019514343 A5 JP2019514343 A5 JP 2019514343A5
- Authority
- JP
- Japan
- Prior art keywords
- domain
- seq
- polypeptide
- fragment
- staphylococcal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662294413P | 2016-02-12 | 2016-02-12 | |
| US62/294,413 | 2016-02-12 | ||
| PCT/IB2017/050763 WO2017137954A2 (en) | 2016-02-12 | 2017-02-10 | Compositions and methods related to antibodies that neutralize coagulase activity during staphylococcus aureus disease |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019514343A JP2019514343A (ja) | 2019-06-06 |
| JP2019514343A5 true JP2019514343A5 (https=) | 2020-03-26 |
| JP7117244B2 JP7117244B2 (ja) | 2022-08-12 |
Family
ID=59563610
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018542268A Expired - Fee Related JP7117244B2 (ja) | 2016-02-12 | 2017-02-10 | 黄色ブドウ球菌疾患の間にコアグラーゼ活性を中和する抗体に関連した組成物および方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US11214600B2 (https=) |
| EP (1) | EP3416979A4 (https=) |
| JP (1) | JP7117244B2 (https=) |
| AU (1) | AU2017218768B2 (https=) |
| WO (1) | WO2017137954A2 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9181329B2 (en) * | 2007-08-31 | 2015-11-10 | The University Of Chicago | Methods and compositions related to immunizing against Staphylococcal lung diseases and conditions |
| AU2013252883B2 (en) * | 2012-04-26 | 2018-05-17 | University Of Chicago | Staphylococcal coagulase antigens and methods of their use |
| MX2021013833A (es) | 2019-05-14 | 2022-03-17 | Univ Chicago | Metodos y composiciones que comprenden variantes de la proteina a de estafilococos (spa). |
| WO2021051136A1 (en) | 2019-09-13 | 2021-03-18 | The University Of Chicago | Methods and compositions for treating staphylococcal infections |
| CN114062665B (zh) * | 2020-08-05 | 2023-04-28 | 菲鹏生物股份有限公司 | 示踪粒子标记目标分子及其制备方法和应用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6610293B1 (en) | 1997-06-16 | 2003-08-26 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine | Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria |
| EP1121149A4 (en) | 1998-08-31 | 2002-03-20 | Inhibitex Inc | IMMUNOTHERAPEUTICS AGAINST STAPHYLOCOCCUS USING DONOR SELECTION AND DONOR STIMULATION |
| AU6033299A (en) | 1998-09-14 | 2000-04-03 | Nabi | Compositions of beta-glucans and specific igiv |
| KR20070058631A (ko) * | 2004-09-22 | 2007-06-08 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | 면역원성 조성물 |
| AR060187A1 (es) * | 2006-03-30 | 2008-05-28 | Glaxosmithkline Biolog Sa | Composicion inmunogenica |
| MY148405A (en) * | 2006-03-30 | 2013-04-30 | Glaxosmithkline Biolog Sa | Immunogenic composition |
| GB0700136D0 (en) * | 2007-01-04 | 2007-02-14 | Glaxosmithkline Biolog Sa | Process for manufacturing vaccines |
| ES2784957T3 (es) | 2009-04-03 | 2020-10-02 | Univ Chicago | Composiciones y métodos relacionados con variantes de la proteína A (SPA) |
| MX2011010735A (es) * | 2009-04-14 | 2012-01-25 | Novartis Ag | Composiciones para inmunizacion contra staphylococcus aureus. |
| JP6002128B2 (ja) | 2010-07-02 | 2016-10-05 | ザ・ユニバーシティ・オブ・シカゴＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃｈｉｃａｇｏ | プロテインＡ（ＳｐＡ）変種に関連する組成物および方法 |
| US9085631B2 (en) * | 2011-04-08 | 2015-07-21 | Nov Vac APS | Proteins and nucleic acids useful in vaccines targeting Staphylococcus aureus |
| AU2013252883B2 (en) * | 2012-04-26 | 2018-05-17 | University Of Chicago | Staphylococcal coagulase antigens and methods of their use |
| EP2841101B1 (en) * | 2012-04-26 | 2019-08-07 | University Of Chicago | Compositions and methods related to antibodies that neutralize coagulase activity during staphylococcus aureus disease |
| WO2015057893A2 (en) * | 2013-10-15 | 2015-04-23 | The Texas A&M University System | Compositions and the use of a fibrinogn binding motif presence in efb and coa for vaccine against staphylococcus aureus and drug delivery |
| EP3096788B1 (en) * | 2014-01-24 | 2019-07-31 | Church, William, R. | Antibody specific to staphylococcus aureus, therapeutic method and detection method using same |
-
2017
- 2017-02-10 WO PCT/IB2017/050763 patent/WO2017137954A2/en not_active Ceased
- 2017-02-10 JP JP2018542268A patent/JP7117244B2/ja not_active Expired - Fee Related
- 2017-02-10 US US16/077,213 patent/US11214600B2/en not_active Expired - Fee Related
- 2017-02-10 EP EP17749960.5A patent/EP3416979A4/en not_active Withdrawn
- 2017-02-10 AU AU2017218768A patent/AU2017218768B2/en not_active Ceased
-
2021
- 2021-12-21 US US17/645,344 patent/US20220227819A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6317670B2 (ja) | ブドウ球菌プロテインａに対する抗体に関連した組成物および方法 | |
| CN101679516B (zh) | 靶向金黄色葡萄球菌ORF0657n的抗原结合蛋白 | |
| JP2019514343A5 (https=) | ||
| RU2770209C2 (ru) | Терапевтические антитела против лиганда cd40 | |
| JP2014525933A5 (https=) | ||
| JP6251730B2 (ja) | 黄色ブドウ球菌（ｓｔａｐｈｙｌｏｃｏｃｃｕｓａｕｒｅｕｓ）疾患の間にコアグラーゼ活性を中和する抗体に関連した組成物および方法 | |
| JP2019511911A5 (https=) | ||
| JP2016529882A5 (https=) | ||
| CN111732654B (zh) | 一种抗SARS-CoV-2的单克隆抗体1E10 | |
| AU2016334290B2 (en) | Antibody to hepatitis B surface antigen and use thereof | |
| JP2018514193A5 (https=) | ||
| KR102058381B1 (ko) | 인간 ｌ１ｃａｍ에 대한 인간화 항체 및 그의 제조 방법 | |
| EP3496750A2 (en) | Combination therapy | |
| WO2020029860A1 (zh) | 针对狂犬病病毒的双特异性抗体及其用途 | |
| US20250145708A1 (en) | Epitope of Regulatory T Cell Surface Antigen and Antibody Specifically Binding Thereto | |
| CN107922482A (zh) | Iii型分泌系统靶向分子 | |
| WO2025242094A1 (zh) | 靶向bdca2的抗体或其抗原结合片段及其应用 | |
| CN116715757A (zh) | 全人源抗狂犬病毒中和抗体及其用途 | |
| RU2015129655A (ru) | Антитело человека, специфичное к матапневмовирусу человека, или антиген-связывающий фрагмент указанного антитела | |
| JP2019511457A5 (https=) | ||
| WO2019128119A1 (zh) | 一种针对破伤风毒素的全人源单克隆中和抗体及其应用 | |
| EP2778173A1 (en) | Antibody directed against anthrax toxins and its uses | |
| US20240059764A1 (en) | ANTIGEN-BINDING PROTEIN TARGETING STAPHYLOCOCCUS AUREUS a-HEMOLYSIS AND APPLICATION THEREOF | |
| JP2007527703A (ja) | 肺炎球菌表面付着因子Ａタンパク質（ＰｓａＡ）に関する結合メンバー | |
| CN115772544B (zh) | 抗vegf-a和ang-2的aav载体 |